What kanna is, its three main alkaloids, its history, the formats it comes in, servings for each, and how to take it safely.

Kanna's status in the United States, what the Louisiana statute actually says, and why local law is worth checking before ordering.

How a kanna serving comes on, how long it runs, and how the alkaloid profile changes the character of what you feel.

Kanna and kava are unrelated plants with different actives, different preparation, and different traditions. A straight comparison of both.

What separates one kanna extract from another: total alkaloid concentration, the alkaloid profile behind the effect, the format, and whether the lab work exists.

The serotonin interaction that matters most, the side effects reported in research, and who should not take kanna.

Luke Storey interviews founder Ryan Latreille on kanna: where the plant comes from, its history in South Africa, and how the extracts are made.

Matt Blackburn interviews founder Ryan Latreille on kanna's alkaloids, lab testing, and which alkaloid profile fits which moment.

Lana Pribic interviews founder Ryan Latreille: the three alkaloids, Khoi and San history, serving guidance, and benefit sharing.

Founder Ryan Latreille on the PT Podcast: kanna's history, its alkaloids, and sourcing high-alkaloid Sceletium with a Khoi tribal leader.

DoubleBlind Magazine covers kanna: its history among the San and Khoi peoples, how mesembrine works, and the work that led to Kanna Extract Co.

Founder Ryan Latreille joins Paul Austin to talk through kanna's three alkaloids, its history, how we source, and safety.

How kanna is grown — propagation, soil, and its unusual growth cycle — and how we source: high-alkaloid strains, no pesticides or synthetic fertilizers, and...

What plant extraction is, how kanna is traditionally prepared, and how our extracts are made: a patented process, a mannitol carrier, and guaranteed minimum concentrations.

Why third-party testing matters for extracts, how to read a certificate of analysis, and how every Kanna Extract Co. lot is tested.

A pilot study on Sceletium tortuosum and mood after unaccustomed exercise: mood held up better with supplementation than with placebo, with no effect on performance...

A summary of Nigel Gericke's chapter on kanna: four centuries of records, the botany of Sceletium, and the modern research on its alkaloids.

A 2022 review of kanna's chemistry: twenty-five alkaloids in four classes, pharmacokinetics, and clinical work in healthy adults.

The first human brain-imaging study on a kanna extract: a single 25mg serving reduced amygdala reactivity to threatening faces.

A 2021 review of kanna's biological properties: its alkaloids, the laboratory findings, and the limits of the evidence so far.